5 Best Performing Healthcare ETFs in 2022

1. First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)

YTD Return as of December 9: 3.37%

The First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) is ranked high among the best performing healthcare ETFs in 2022. The fund has gained 3.37% year to date, as of December 9, and has outperformed the S&P 500 by over 20%. The fund has an expense ratio of 0.60% and a yield of 1.09%. The fund mirrors the returns of the Nasdaq US Smart Pharmaceuticals Index and employs a full replication technique.

The First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) has 30 holdings and a top ten holdings concentration of 64.28%. One the fund’s top ten holdings is Amgen, Inc. (NASDAQ:AMGN). This December, Oppenheimer analyst Jay Olson raised his price target on Amgen, Inc. (NASDAQ:AMGN) to $310 from $300 and reiterated an Outperform rating on the shares.

At the close of Q3 2022, Two Sigma Advisors was the dominant investor in Amgen, Inc. (NASDAQ:AMGN) and disclosed a position worth $379.4 million in the company.

Here is what Smead Capital Management had to say about Amgen Inc. (NASDAQ:AMGN) in its third-quarter 2022 investor letter:

“Two things are very noticeable right off the top. First, sometimes you have to be happy losing less in a bear market environment so that you have more of your capital to grow in the next bull market. We are never really happy losing money. Second, 2022 is likely to be our third year of existence as a fund to lose money for the year. This year would join 2008 and 2018 in this undistinguished category. Our biggest detractors was dominated by  Amgen (NASDAQ:AMGN). Consumer/investor fears about media and e-commerce hit WBD and EBAY and profit taking in Amgen came from early 2022 strength.”

You can also take a look at 11 Best ADR Stocks To Buy and 10 Best Halal Dividend Stocks To Buy.